Posted by Michael Wonder on 07 Oct 2021
Ban on negotiating Medicare drug prices under pressure
7 October 2021 - Negotiating Medicare drug prices is a linchpin of President Joe Biden's ambitious health care agenda.
Donna Weiner looks at Medicare’s prescription drug program from two different points of view.
As a participant, she wants to pay less for her medicines, which cost her about $6,000 a year. As a retired accountant who spent 50 years handling the books for companies, she sees a way to get there.
